Stay updated with breaking news from Malignancy Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than half.
/PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and...
ANCHOR data support screening and treatment for anal HSIL in those ages 35 and up
For the first time, researchers have shown that treating anal HSIL lesions prevents cancer progression in HIV.